Ukrainian startup Audubon Bioscience sells services of procurement cancer cells and human plasma for $6.5M in 2021.
- Rostislav Semikov, from Zaporizhzhia, founded Audubon Bioscience, which collects human cancer tissues, cells, and plasma for delivery to research institutes and companies.
- Semikov’s company is engaged in biobanking: it collects and stores human biosamples: tissue, blood serum and plasma, synovial fluid, and cells. Another component of their business is scientific services.
- Audubon Bioscience sends biosamples to research institutes and companies to test and develop new diagnostics and drugs.
- The business model is simple: customers pay the startup to collect, process, and deliver samples.
- In 2016, the company’s revenue was $118,000 and reached $6.5M in 2021.
